Anupam Rasayan India Ltd. News and Updates

Name: Latest research reports of Anupam Rasayan India Ltd. authored by Prabhudas Lilladhar and published by - Trendlyne research reports.
Item: Anupam Rasayan India Ltd.
Rating: 3
Author: Prabhudas Lilladhar

Keep track of all breaking news on Anupam Rasayan India Ltd. from all sources in a single place.

Load latest

Anupam Rasayan India Ltd.

12 Mar 2021

856.30

0.92%

IPO Note - Exciting Chemistry - Subscribe

IPO Note: Anupam Rasayan India Ltd.

Prabhudas Lilladhar

Manufacturing (CSM) company, operates in Life sciences (95% of rev) and other specialty chemicals (5%) verticals. It is favorably placed in the sweet spot to capture the rising demand for specialty chemicals given its strong relationships with MNCs (Key clients- Syngenta, Sumitomo and UPL), leadership competencies into multi-step synthesis & complex chemistries such as etherification, hydrogenation, alkylation, nitration, etc and superior...

Promoters pledged 3.05% of shares in last quarter. Total pledge stands at 19.52% of promoter holdings

Anupam Rasayan India Ltd.

10 Mar 2021

856.30

0.92%

Anupam Rasayan India Limited IPO Note 10032021

IPO Note: Anupam Rasayan India Ltd.

HDFC Securities

Anupam Rasayan India Limited IPO Note Issue Open: Mar 12 Mar 16, 2021 Price Band: Rs. 553 555 (discount of Rs.55 for eligible employees) *Issue Size: 13,693,694 eq shares (including Employee Reservation of 220,000 Eq sh) *Issue Size: Rs. 757.3 760.0 cr Reservation for: QIB Upto 50% eq sh Non Institutional atleast 15% eq sh Retail atleast 35% eq sh

Promoters pledged 3.05% of shares in last quarter. Total pledge stands at 19.52% of promoter holdings

Anupam Rasayan India Ltd.

10 Mar 2021

856.30

0.92%

Anupam Rasayan India Ltd. IPO Note

IPO Note: Anupam Rasayan India Ltd.

Ashika Research

Anupam Rasayan India Ltd. (ARIL) is one of the leading companies engaged in the custom synthesis and manufacturing of specialty chemicals in India (Source: F&S; Report). The company evolved into custom synthesis and manufacturing of life science related specialty chemicals and...

Anupam Rasayan India.. has an average target of 735.00 from 1 broker.

Anupam Rasayan India Ltd.

10 Mar 2021

856.30

0.92%

Anupam Rasayan India - IPO

IPO Note: Anupam Rasayan India Ltd.

ICICI Securities Limited

To expand business by capitalising on industry opportunities, organic, inorganic growth network In 2019, the Indian market for custom synthesis and manufacturing was valued at US$11.5 billion in 2019 for specialty chemicals accounting for ~6% of the global custom synthesis and manufacturing market. Custom synthesis manufacturing is on the rise in India while the contract research and manufacturing services market is expected to grow at 12% in the next five years, owing to strong growth from end-use demand. In addition, the China...

Anupam Rasayan India.. has an average target of 735.00 from 1 broker.

VOTE: Is Anupam Rasayan India Ltd. worth buying?

67 Votes:

Buy 80.6%

Sell 16.42%

Hold 2.99%

RESEARCH REPORTS

Hold SEE REPORTS >

pdf

Accumulate SEE REPORTS >

pdf

New 52W High today

Anupam Rasayan India Ltd. News and Updates

Keep track of all breaking news on Anupam Rasayan India Ltd. from all sources in a single place.